EWTX R&D Expenses
Edgewise Therapeutics Inc · R&D Expenses
EWTX R&D Expenses
Latest reported$171.27Mperiod ending
EWTX R&D Expenses ($8.62M → $171.27M)
Annual R&D Expenses
High-resolution chart · PNG
EWTX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 151,389,000 | |
| 126,966,000 | |
| 90,905,000 | |
| 54,032,000 | |
| 32,189,000 | |
| 14,798,000 | |
| 8,624,000 |